{
  "id": 16642605,
  "title": "Biomarkers identified for cytokine release syndrome risk after CAR T-cell therapy",
  "url": "https://urgent.news/2026/10/26/biomarkers-identified-for-cytokine-release-syndrome-risk-after-car-t",
  "topic": "science",
  "section": "Science",
  "published": "2026-10-26T18:20:19.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-10-biomarkers-cytokine-syndrome-car-cell.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "For patients with autoimmune disease, higher baseline B-cell counts and systemic inflammation are associated with development of cytokine release syndrome (CRS) after chimeric antigen receptor (CAR) T-cell therapy, according to a study published in the November issue of The Lancet Rheumatology.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}